It is simple as that. We are gonna make a boat load of money when we get bought out for a huge sum from a big pharma. I'm 100% convinced and have bought A LOT of shares. Call me a fool, but we will see who is right. Good luck to all.
Sentiment: Strong Buy
Say's someone SO far underwater with this garbage. It is always someone that pumps the hell out of this garbage to get out of it.
You are pumping on Yahoo MB. The stock is under control of the warrant sellers and the MM trying to suck others in. DO YOU understand that/ .03 is the magic point. .01 will soon become the magic point. It's called death spiral financing. Google the term. Do some actual DD istead of playing the pumping game on a yahoo MB.
Pfizer is a great candidate:
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech.
For Pfizer, the deal marks another new foray in the world of early-stage drug development. Investigators from both groups will work together on preclinical programs, with Pfizer stepping in to take charge of anything that reaches the clinic. The pharma giant has been stepping up its dealmaking activities recently after completing a global R&D restructuring, carving billions of dollars out of its R&D budget, and forming research alliances with small companies such as Nodality in autoimmune disease and Bind Therapeutics for nanotech drugs.
"This partnership is a great example of how Pfizer is seeking to innovate new capabilities in cutting-edge science and technology platforms with the aim of delivering safer, more effective cancer medicines to patients," said Robert Abraham, the senior vice president and chief scientific officer of Pfizer's Oncology Research Unit. "Pfizer's investment in CytomX's emerging Probody Platform is an important component of our overall strategic focus to advancing the next generation of ADCs and reflects the disruptive potential of this approach."
I just bought 82,500 shares @ 0.3595; lately I have noticed a trend of big pharma partnering or acquiring promising new technology. Big pharma likes micro caps to be incubators for future successful therapies.